Found 48 matching trials
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma PHASE1 This study is a single-center, open Phase I study, to observe the effective...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP PHASE1 This is an open label, multicenter, dose escalation, phase Ib study to dete...
Show More Location
Institut Jules Bordet
Learn More & Join Trial
Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma PHASE1 The main purpose of this study is to determine the recommended doses of sel...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma PHASE2 Phase 2, single-arm, open, non-randomized, multicenter study of the SINE™ c...
Show More Status
Active Not Recruiting
Location
Hospital Germans Trials i Pujol
Learn More & Join Trial
Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19 PHASE2 The main purpose of this study is to evaluate the activity, safety and redu...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas PHASE1 This is a phase 1b study of investigational drug selinexor in combination w...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma PHASE2 Primary central nervous system diffuse large B-cell lymphoma (PCNSL-DLBCL) ...
Show More Location
Beijing Tongren Hospital, Capital Medical University
Learn More & Join Trial
Golidocitinib Combined With Selinexor for CAEBVD PHASE2 This study is a multicenter, prospective, single-arm clinical investigation...
Show More Location
Beijing Friendship Hospital
Learn More & Join Trial
Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma PHASE2 The purpose of this study is to find out what effects new combinations of t...
Show More Status
Active Not Recruiting
Location
Arthur J.E. Child Comprehensive Cancer Centre
Learn More & Join Trial
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 The purpose of this Phase 2/3 study is to evaluate efficacy and safety of t...
Show More Status
Active Not Recruiting
Location
Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers
Learn More & Join Trial